DYVZED Trademark
DYVZED is a USPTO trademark filed by Pfizer Inc.. Status: Pending.
Prosecution Summary
**Trademark Summary** The standard character mark **DYVZED** covers pharmaceutical preparations for treating various diseases and disorders including autoimmune, cardiovascular, infectious, inflammatory, cancer, and diabetes in International Class 005, along with classifications in Domestic Classes 006, 018, 044, 046, 051, and 052. It is owned by **Pfizer Inc.**, a Delaware corporation with a principal address at 66 Hudson Boulevard East, New York, New York. The application is under a Notice of Allowance on an intent-to-use basis, with a **first extension of time to file a Statement of Use granted** on March 6, 2026. No oppositions or legal proceedings are present. **Recent Activity** Filed on April 3, 2025, the application was approved for publication on July 25, 2025, and published
Trademark Facts
| Mark | DYVZED |
|---|---|
| Serial Number | 99119087 |
| Status | Pending |
| Filing Date | 2025-04-03 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Pfizer Inc. |
| Attorney of Record | Heather A. McDonald |
| Prosecution Events | 13 |
| Latest Event | EXRA on 2026-03-07 |
Goods & Services
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use